Squarepoint Ops LLC

Position in IPSC — Century Therapeutics, Inc.

CIK 1642575 NEW YORK, NY

Position in IPSC

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$220,865

-$49,214 QoQ

Shares Held

90,149

-24.6% QoQ

Ownership

0.050%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#48

of 98 holders

Holding Since

Dec 2022

12 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Healthcare · as of Jun 30, 2026

Squarepoint Ops LLC holds $1,234,876,212 across 255 Biotechnology names. IPSC ranks #203 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	198,567	$123,814,467
2	BBIO	BridgeBio Pharma, Inc.	1,191,732	$88,760,199
3	ALNY	Alnylam Pharmaceuticals, Inc.	233,999	$70,440,718
4	INSM	INSMED Inc	616,464	$65,727,391
5	ARGX	Argenx SE	58,400	$54,181,768
6	RYTM	Rhythm Pharmaceuticals, Inc.	422,921	$46,956,918
7	APGE	Apogee Therapeutics, Inc.	290,713	$38,586,336
8	AXSM	Axsome Therapeutics, Inc.	154,605	$37,842,665

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$220,865	90,149	-24.6%	Shares	Defined	2026-08-14
2026-03-31	$270,079	119,504	-49.4%	Shares	Defined	2026-05-15
2025-09-30	$117,554	236,053	+483.1%	Shares	Defined	2025-11-14
2025-06-30	$22,628	40,480	-69.5%	Shares	Defined	2025-08-27
2025-03-31	$63,274	132,929	-19.4%	Shares	Defined	2025-08-27
2024-12-31	$166,519	164,871	+56.0%	Shares	Defined	2025-02-14
2024-09-30	$180,741	105,697	+89.4%	Shares	Defined	2024-11-14
2023-12-31	$185,312	55,817	-34.9%	Shares	Defined	2024-02-14
2023-09-30	$171,400	85,700	+29.5%	Shares	Defined	2023-11-14
2023-06-30	$209,046	66,154	-1.4%	Shares	Defined	2023-08-14
2023-03-31	$232,843	67,102	+181.2%	Shares	Defined	2023-05-15
2022-12-31	$122,432	23,866	—	Shares	Defined	2023-02-14
No filing history on record for this holder in this stock.